Catalog Number 3315040 |
Device Problem
Loss of or Failure to Bond (1068)
|
Patient Problems
Pain (1994); Discomfort (2330)
|
Event Date 12/10/2022 |
Event Type
Injury
|
Event Description
|
Patient had attunne primary knee surgery.30 days after the surgery, she began with persistent pain and discomfort while walking.The dr.Detected a loosening in the tibial plateau, therefore it must be replaced, performing tibial revision.Did the patient experience an adverse event such as infection, non-union, allergic reaction, osteoporosis, overloading, pain, degenerative diseases, bleeding or oozing? unknown, did the patient require revision surgery or hardware removal? unknown, patient status/ outcome / consequences : no, was other medical intervention (e.G.X-rays, additional procedures, prescriptions, otc, revision) required: unknown, is the patient part of a clinical study : unknown, ip (b)(4), device property of : none, device in possession of : none.By checking this box i certify that all information that are known/available has been disclosed.If any new information will be made available, the additional information will be submitted through cst.
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).Dmf# (b)(4).Trade name gentamicin sulphate, active ingredient(s) gentamicin sulphate, dosage form - powder, strength 1.0g active in our cements.Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial , a follow-up will be filed as appropriate.
|
|
Manufacturer Narrative
|
Product complaint (b)(4).Investigation summary; no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.Device history lot; a manufacturing record evaluation (mre), was not possible because the required lot code was not provided.H10 additional narrative: added: d6a, d6b corrected: d3, g1.
|
|
Event Description
|
Additional information received: a.Was there a surgical delay during revision surgery? what was the length of the delay? there was no surgical delay.B.Tibial loosening was indicated.Please provide the loosening interface, cement manufacturer.If depuy cement was used, provide details and the quantity of the product.: the doctor detected the loosening of the plate, and the patient reported pain.Depuy 3315040 2-dose cement was used.C.What is the affected side? left or right? left side.
|
|
Search Alerts/Recalls
|
|